Mission Therapeutics (United Kingdom)

A rich pipeline of first-in-class therapeutics that selectively target specific disease-associated DUBs, including USP30. Mission has a collaborative, science-driven culture with strong links to key academic and research centres. Selectively targeting DUBs to treat diseases, including Parkinsons, with high unmet medical need.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Mission Therapeutics (United Kingdom).

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

A rich pipeline of first-in-class therapeutics that selectively target specific disease-associated DUBs, including USP30. Mission has a collaborative, science-driven culture with strong links to key academic and research centres. Selectively targeting DUBs to treat diseases, including Parkinsons, with high unmet medical need.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.